Oral glycoprotein Iib/IIIa receptor inhibitors in patients with cardiovadcular disease: why were the results so unfavourable

Frank Leebeek, Eric Boersma, CP Cannon, FJ van de Werf, Maarten Simoons

Research output: Contribution to journal › Article › Academic › peer-review

22 Citations (Scopus)

Research programs

@article{c05863d58e8643b0b029867d358346b3,

title = "Oral glycoprotein Iib/IIIa receptor inhibitors in patients with cardiovadcular disease: why were the results so unfavourable",

author = "Frank Leebeek and Eric Boersma and CP Cannon and {van de Werf}, FJ and Maarten Simoons",

year = "2002",

doi = "10.1053/euhj.2001.2751",

language = "Undefined/Unknown",

volume = "23",

pages = "444--457",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Oral glycoprotein Iib/IIIa receptor inhibitors in patients with cardiovadcular disease: why were the results so unfavourable

AU - Leebeek, Frank

AU - Boersma, Eric

AU - Cannon, CP

AU - van de Werf, FJ

AU - Simoons, Maarten

PY - 2002

Y1 - 2002

U2 - 10.1053/euhj.2001.2751

DO - 10.1053/euhj.2001.2751

M3 - Article

SN - 0195-668X

VL - 23

SP - 444

EP - 457

JO - European Heart Journal

JF - European Heart Journal

ER -